{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"7","upperLimit":"161","value":"46"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"72"}],"units":"Participants"}],"description":"median and range","dispersionType":"Full Range","groups":[{"description":"CONDITIONING REGIMEN: Patients receive fludarabine phosphate IV over 1 hour on days -6 to -2 and cyclophosphamide IV over 1-2 hours on day -6. Patients with low risk of graft failure (multi-agent chemotherapy in the last 3 months or history of autologous transplant) receive 200cGy TBI on day -1. Patients with high risk of graft failure receive 300 cGy TBI on day -1.\n\nUMBILICAL CORD BLOOD TRANSPLANT: Patients undergo donor umbilical cord blood infusion on day 0.\n\nIMMUNOSUPRESSIVE THERAPIES: Patients receive cyclosporine IV over 1 hour every 8-12 hours on days 0 to +180 and mycophenolate mofetil IV or PO every 8 hours on days -3 to +96.\n\nAllogeneic Hematopoietic Stem Cell Transplantation: Undergo umbilical cord blood transplant","id":"OG000","title":"Treatment (Chemotherapy, Transplant)"}],"paramType":"MEDIAN","reportingStatus":"POSTED","timeFrame":"By 6 months","title":"Time to Platelet Engraftment of > 20,000 Cells Per mm3","type":"SECONDARY","unitOfMeasure":"days"}